The Neurontin legacy--marketing through misinformation and manipulation.
about
Reporting bias in medical research - a narrative reviewThe haunting of medical journals: how ghostwriting sold "HRT"Gabapentin for fibromyalgia pain in adultsGabapentin for chronic neuropathic pain and fibromyalgia in adultsGabapentin or pregabalin for the prophylaxis of episodic migraine in adultsGabapentin for chronic neuropathic pain and fibromyalgia in adultsRisk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of "edge effect" and cultivating an ethical bridge between omics innovations and societyMedical students' exposure to and attitudes about the pharmaceutical industry: a systematic reviewPatented drug extension strategies on healthcare spending: a cost-evaluation analysisPharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012Who has used internal company documents for biomedical and public health research and where did they find them?Guidelines in the management of diabetic nerve pain: clinical utility of pregabalin.JUPITER: a few words of caution.Gabapentin for chronic neuropathic pain in adults.Challenges to physician-patient communication about medication use: a window into the skeptical patient's world.Models for financing the regulation of pharmaceutical promotion.Does the pharmaceutical industry influence guidelines?: two examples from Germany.Systematic analysis of hydroxyethyl starch (HES) reviews: proliferation of low-quality reviews overwhelms the results of well-performed meta-analyses.A plea for a more epidemiological and patient-oriented pharmacovigilance.Management of painful diabetic neuropathy: guideline guidance or jungle?Publication bias, with a focus on psychiatry: causes and solutions.Gabapentin for fibromyalgia pain in adults.The future of conflicts of interest: a call for professional standards.Systematic approach: an evidence management strategy for better decision-making.[Pain measurement in animal models].Contending professions: sciences of the brain and mind in the United States, 1850-2013.Diagnosis and management of trigeminal neuropathic pains.Pharmaceutical industry discursives and the marketization of nursing work: a case example.Relationships between physicians and Pharma: Why physicians should not accept money from the pharmaceutical industry.[Knowledge transfer between research and practice].Hidden in plain sight marketing prescription drugs to consumers in the twentieth century.An unbiased scientific record should be everyone's agendaOff-label prescribing in palliative care – a cross-sectional national survey of Palliative Medicine doctors
P2860
Q21203744-46CC3199-6CD8-4124-8F20-6C5303F0938AQ21563448-6CAF0D93-7931-483B-A07E-85779DE354B2Q24185818-DD237811-CC83-4AA0-9A48-E508F4CC0055Q24194998-B89A392D-1356-45DB-A29E-A566F08AD26CQ24201830-3DB9F5B5-A94F-4A8F-A13B-E45F9D3640C4Q24235709-FCB0860A-D1A9-4AB6-8CE7-EE5DB9333904Q24289220-EAC82FBD-E071-4C85-AC3E-8BB74F66CB40Q28478255-77413E85-3375-48C7-A88F-C54433EBE2ABQ28533630-F7B4119C-F115-406B-A445-BD1FF7C05D66Q28552890-91698637-D76F-43F9-957A-3B1EA9D41F4EQ28657906-B6B72B6E-6ED4-4DF3-A455-DFADB1D4EF98Q30537158-0C38B492-116C-4AAE-B45B-6AAC71C954B1Q33557560-738CEB1B-36A9-4C7D-B367-3AF2B3204693Q34557703-62B6D8A6-EF7C-4F0F-B9E6-691D95B296CDQ35684204-01F0B2CD-9C6A-41ED-B0BB-823A9D62E52AQ36138721-3FF4FE71-864B-49A7-950C-EF6BAB3822E4Q37199193-9D1D704E-964F-4D14-BDD3-9F6AEF89AF83Q37199531-4D2C7779-C493-47A9-8890-12AB55231AAFQ37902956-B79C581A-1696-4974-AA82-D326757B6347Q38012664-CA8470BD-1BC8-460A-9123-C3F874BDF86EQ38108574-1602C5C1-DD42-41B7-A92E-315972F9547DQ39043205-3CF160AF-3D92-47DB-9C28-D4A1CEA07557Q39537482-BD212CCD-B14A-4584-A4CB-0A05A9D777C6Q43533882-A6F00AE8-9109-43EA-AE96-906D807BA108Q43636901-D8672B17-AE39-44E2-B28C-C604B640D287Q46179405-FA918381-47AB-493B-A0B9-7952841FA00CQ48648568-307A533B-36D2-4C08-9DD3-0837B5FD8161Q48651343-DADE1D73-FD5D-4991-9C5F-F8A7918861F9Q49507167-5BA3996F-37C0-45F9-8723-D5687C1F5C07Q52895706-87C7F0C0-E12C-4FB2-8A15-5173CC986774Q53080911-701B1ECA-3908-4957-B27F-FA929FECADA3Q57278108-09F6533A-0E5F-413F-B5FE-A6F8782FE696Q57359747-115B40C9-027D-4171-B95F-187E18013D4F
P2860
The Neurontin legacy--marketing through misinformation and manipulation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The Neurontin legacy--marketing through misinformation and manipulation.
@ast
The Neurontin legacy--marketing through misinformation and manipulation.
@en
The Neurontin legacy--marketing through misinformation and manipulation.
@nl
type
label
The Neurontin legacy--marketing through misinformation and manipulation.
@ast
The Neurontin legacy--marketing through misinformation and manipulation.
@en
The Neurontin legacy--marketing through misinformation and manipulation.
@nl
prefLabel
The Neurontin legacy--marketing through misinformation and manipulation.
@ast
The Neurontin legacy--marketing through misinformation and manipulation.
@en
The Neurontin legacy--marketing through misinformation and manipulation.
@nl
P356
P1476
The Neurontin legacy--marketing through misinformation and manipulation.
@en
P2093
C Seth Landefeld
Michael A Steinman
P304
P356
10.1056/NEJMP0808659
P407
P577
2009-01-01T00:00:00Z